Pfizer acquires 40% stake in Brazilian generics firm Teuto
This article was originally published in Scrip
Pfizer says it is aiming to boost its presence in Brazil by acquiring a 40% stake in the local generics firm Teuto, in a deal worth an initial $240 million. Through the agreement, the two companies will develop and commercialise generic medicines, said Pfizer.
You may also be interested in...
Financial ties between companies and healthcare bodies distort the production and use of evidence, claims a paper co-authored by researchers, clinicians and decision makers, including a representative of Germany’s HTA body, IQWiG.
Meindert Boysen, head of NICE’s Centre For Health Technology Evaluation, shares advice for companies aiming to get their medicine to patients. His golden rules: engage in early advice and be more realistic about pricing.